Time to control of ocular inflammatory disease with systemic immunosuppression is adversely impacted by greater socioeconomic disadvantage as measured by ADI.
Trudrung et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: